EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer

Giovanni Tossetta iD, Sonia Fantone iD, Daniela Marzioni, Roberta Mazzucchelli iD

Cancers · 02.06.2023 · 15 (11) · 3037

DOI: 10.3390/cancers15113037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 02.06.2023. Verfasst von Giovanni Tossetta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, 60126 Ancona, Italy. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is the second most common cancer in men worldwide. Prostate cancer can be treated by surgery or active surveillance when early diagnosed but, when diagnosed at an advanced or metastatic stage, radiation therapy or androgen-deprivation therapy is needed to reduce cancer progression. However, both of these therapies can cause prostate cancer resistance to treatment. Several studies demonstrated that oxidative stress is involved in cancer occurrence, development, progression and treatment resistance. The nuclear factor erythroid 2-related factor 2 (NRF2)/KEAP1 (Kelch-Like ECH-Associated Protein 1) pathway plays an important role in protecting cells against oxidative damage. Reactive oxygen species (ROS) levels and NRF2 activation can determine cell fate. In particular, toxic levels of ROS lead physiological cell death and cell tumor suppression, while lower ROS levels are associated with carcinogenesis and cancer progression. On the contrary, a high level of NRF2 promotes cell survival related to cancer progression activating an adaptive antioxidant response. In this review, we analyzed the current literature regarding the role of natural and synthetic compounds in modulating NRF2/KEAP1 signaling pathway in prostate cancer.

Schlagwörter

Stichwörter der Autor:innen

KEAP1NRF2antioxidantschemotherapycompoundsnaturalprostate cancersignalingsynthetic

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Department of Biomedical Sciences and Public Health, Section of Pathological Anatomy, Università Politecnica delle Marche, 60126 Ancona, Italy.

ORCID-Profile: Giovanni Tossetta, Sonia Fantone, Roberta Mazzucchelli

Zitieren

APA

Tossetta, G., Fantone, S., Marzioni, D., & Mazzucchelli, R. (2023). Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer. Cancers, 15(11), 3037. https://doi.org/10.3390/cancers15113037

Vancouver

Tossetta G, Fantone S, Marzioni D, Mazzucchelli R. Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer. Cancers. 2023;15(11):3037. doi:10.3390/cancers15113037

BibTeX
@article{Tossetta2023,
  author = {Tossetta, Giovanni and Fantone, Sonia and Marzioni, Daniela and Mazzucchelli, Roberta},
  title = {Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {3037},
  doi = {10.3390/cancers15113037}
}
Kostenlos starten →